Copyright 2003 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2003
TWO RECENT publications1,2 of the findings of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) have captured the interest of the media and physicians worldwide. The results have important implications for the treatment of hypertension. This double-blind randomized trial originally included more than 40 000 relatively high-risk hypertensive patients with a mean age of 67 years who were followed up over a 5-year period.
Moser M. Results of ALLHAT: Is This the Final Answer Regarding Initial Antihypertensive Drug Therapy? Arch Intern Med. 2003;163(11):1269–1273. doi:10.1001/archinte.163.11.1269
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: